Related Experiment Video
Updated: Jan 28, 2026

A Simple Method to Identify Kinases That Regulate Embryonic Stem Cell Pluripotency by High-throughput Inhibitor Screening
Published on: May 12, 2017
A Diacylglycerol Kinase Inhibitor, R-59-022, Blocks Filovirus Internalization in Host Cells
Corina M Stewart1,2,3, Stephanie S Dorion4, Marie A F Ottenbrite5
1Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, ON K1H 8M5, Canada. cwark095@uottawa.ca.
Abstract:
Filoviruses, such as Ebola virus (EBOV) and Marburg virus, are causative agents of unpredictable outbreaks of severe hemorrhagic fevers in humans and non-human primates. For infection, filoviral particles need to be internalized and delivered to intracellular vesicles containing cathepsin proteases and the viral receptor Niemann-Pick C1. Previous studies have shown that EBOV triggers macropinocytosis of the viral particles in a glycoprotein (GP)-dependent manner, but the molecular events required for filovirus internalization remain mostly unknown. Here we report that the diacylglycerol kinase inhibitor, R-59-022, blocks EBOV GP-mediated entry into Vero cells and bone marrow-derived macrophages. Investigation of the mode of action of the inhibitor revealed that it blocked an early step in entry, more specifically, the internalization of the viral particles via macropinocytosis. Finally, R-59-022 blocked viral entry mediated by a panel of pathogenic filovirus GPs and inhibited growth of replicative Ebola virus. Taken together, our studies suggest that R-59-022 could be used as a tool to investigate macropinocytic uptake of filoviruses and could be a starting point for the development of pan-filoviral therapeutics.
Insights
A diacylglycerol kinase inhibitor, R-59-022, effectively blocks Ebola virus (EBOV) entry into cells by inhibiting macropinocytosis. This finding offers a potential therapeutic strategy against filoviral infections.
Area of Science:
- Virology
- Cell Biology
- Drug Discovery
Background:
- Filoviruses, including Ebola virus (EBOV) and Marburg virus, cause severe hemorrhagic fevers.
- Filovirus entry into host cells requires internalization and delivery to intracellular vesicles containing cathepsin proteases and Niemann-Pick C1.
- EBOV entry is known to involve glycoprotein (GP)-dependent macropinocytosis, but the precise molecular mechanisms remain unclear.
Purpose of the Study:
- To investigate the molecular events governing filovirus internalization.
- To identify potential therapeutic targets for filoviral infections.
Main Methods:
- Utilized the diacylglycerol kinase inhibitor R-59-022 to study EBOV entry.
- Examined the effect of R-59-022 on viral particle internalization via macropinocytosis in Vero cells and macrophages.
- Tested R-59-022 against various pathogenic filovirus GPs and replicative EBOV.
Main Results:
- R-59-022 effectively inhibited EBOV glycoprotein (GP)-mediated entry into Vero cells and macrophages.
- The inhibitor blocked an early step in viral entry, specifically the internalization of viral particles through macropinocytosis.
- R-59-022 demonstrated efficacy against a range of filovirus GPs and inhibited the replication of Ebola virus.
Conclusions:
- Diacylglycerol kinase inhibition by R-59-022 represents a novel strategy to block filovirus entry.
- R-59-022 can serve as a valuable research tool for studying filovirus macropinocytosis.
- This inhibitor shows promise as a potential starting point for developing broad-spectrum antiviral therapeutics against filoviruses.
Related Concept Videos
Protein Kinases and Phosphatases
Protein kinases
Many proteins in the cell are regulated by phosphorylation, the addition of a phosphate group. A family of enzymes called kinases...
Protein Kinases and Phosphatases
Internal Receptors
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Internal Energy

